Patents by Inventor Shawn G. Watson

Shawn G. Watson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140037550
    Abstract: Stable ultrapure colchicine compositions comprising ultrapure colchicine and a pharmaceutically acceptable excipient are described. The compositions can be tablets. Methods for preparing such compositions and methods of use are also disclosed. Methods of treating gout flares with colchicine compositions are also disclosed.
    Type: Application
    Filed: October 4, 2013
    Publication date: February 6, 2014
    Applicant: TAKEDA PHARMACEUTICALS U.S.A., INC.
    Inventors: Matthew W. Davis, Shawn G. Watson, Hengsheng FENG
  • Publication number: 20110263716
    Abstract: Stable ultrapure colchicine compositions comprising ultrapure colchicine and a pharmaceutically acceptable excipient are described. The compositions can be tablets. Methods for preparing such compositions and methods of use are also disclosed. Methods of treating gout flares with colchicine compositions are also disclosed.
    Type: Application
    Filed: July 1, 2011
    Publication date: October 27, 2011
    Applicant: MUTUAL PHARMACEUTICAL COMPANY, INC
    Inventors: Matthew W. DAVIS, Shawn G. Watson, Hengsheng FENG
  • Publication number: 20110184061
    Abstract: Disclosed herein are thiocolchicine and colchicine analogs and derivatives suitable for use as a muscle relaxant, an anti-inflammatory agent, an anti-gout agent, an anti-proliferative agent, or an anti-cancer agent; methods of making the compounds, and compositions comprising the compounds.
    Type: Application
    Filed: January 20, 2011
    Publication date: July 28, 2011
    Inventors: Kurt R. Nielsen, Rajesh Manchanda, Tong Sun, Shawn G. Watson
  • Publication number: 20090298948
    Abstract: Stable ultrapure colchicine compositions comprising ultrapure colchicine and a pharmaceutically acceptable excipient are described. The compositions can be tablets. Methods for preparing such compositions and methods of use are also disclosed. Methods of treating gout flares with colchicine compositions are also disclosed.
    Type: Application
    Filed: August 21, 2009
    Publication date: December 3, 2009
    Applicant: Mutual Pharmaceutical Company, Inc.
    Inventors: Mathew W. DAVIS, Shawn G. WATSON, Hengsheng FENG
  • Publication number: 20090215904
    Abstract: Stable ultrapure colchicine compositions comprising ultrapure colchicine and a pharmaceutically acceptable excipient are described. The compositions can be tablets. Methods for preparing such compositions and methods of use are also disclosed. Methods of treating gout flares with colchicine compositions are also disclosed.
    Type: Application
    Filed: May 13, 2009
    Publication date: August 27, 2009
    Applicant: MUTUAL PHARMACEUTICAL COMPANY, INC.
    Inventors: Matthew W. Davis, Shawn G. Watson, Hengsheng Feng
  • Publication number: 20090170952
    Abstract: Stable ultrapure colchicine compositions comprising ultrapure colchicine and a pharmaceutically acceptable excipient are described. The compositions can be tablets. Methods for preparing such compositions and methods of use are also disclosed. Methods of treating gout flares with colchicine compositions are also disclosed.
    Type: Application
    Filed: March 20, 2009
    Publication date: July 2, 2009
    Applicant: MUTUAL PHARMACEUTICAL COMPANY, INC.
    Inventors: Matthew W. DAVIS, Shawn G. WATSON, Hengsheng FENG
  • Publication number: 20090093548
    Abstract: Stable ultrapure colchicine compositions comprising ultrapure colchicine and a pharmaceutically acceptable excipient are described. The compositions can be tablets. Methods for preparing such compositions and methods of use are also disclosed. Methods of treating gout flares with colchicine compositions are also disclosed.
    Type: Application
    Filed: October 6, 2008
    Publication date: April 9, 2009
    Applicant: MUTUAL PHARMACEUTICAL COMPANY, INC
    Inventors: Mathew W. Davis, Shawn G. Watson, Hengsheng Feng